Warmink-Perdijk, Willemijn D. B. http://orcid.org/0000-0003-1223-4923
Peters, Lilian L.
Tigchelaar, Ettje F.
Dekens, Jackie A. M.
Jankipersadsing, Soesma A.
Zhernakova, Alexandra
Bossers, Willem J. R.
Sikkema, Jan
de Jonge, Ank
Reijneveld, Sijmen A.
Verkade, Henkjan J.
Koppelman, Gerard H.
Wijmenga, Cisca
Kuipers, Folkert
Scherjon, Sicco A.
Funding for this research was provided by:
UMCG Hereditary Metabolic Diseases Fund
Ubbo Emmius Foundation
European Union, the Northern Netherlands Alliance (SNN), the provinces of Friesland and Groningen and the municipality of Groningen
Philips provided continuous measurement devices for the add-on initiative within Lifelines NEXT
Netherlands Organisation for Scientific Research (NWO) VIDI grand (016.178.056)
European Research Council ERC starting Grand (ERC- 715772)
Article History
Received: 24 June 2019
Accepted: 7 February 2020
First Online: 25 February 2020
Compliance with ethical standards
:
: The authors declare no conflict of interest. Although Philips is a partner in the Newborn project, the company has no influence on or participation in the analyses and publication of the results of the data from their devices.
: Informed consent was obtained from all individuals included in the study.
: The Lifelines NEXT study was approved by the ethics committee of the University Medical Center Groningen, document number METC UMCG METc2015/600.